Novartis’ Cosentyx and Pfizer’s Xeljanz Leave the Most on the Table with Psoriatic Arthritis Switch Brands, According to Spherix Global Insights

EXTON, Pa., Sept. 13, 2019 /PRNewswire/ -- The fourth annual patient chart audit included in Spherix's RealWorld Dynamix™: Biologic/Small Molecule Switching in PsA (US) service includes the feedback of 192 US rheumatologists…
Continue Reading »